The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Coagulation Factor VIIa-Global Market Insights and Sales Trends 2024
Synopsis
Recombinant activated factor VII (rFVIIa) binds to exposed tissue factor at the place of tissue and vascular injury. Thrombin generated by this process activates platelets and the coagulation cascade.
The global Coagulation Factor VIIa market size is expected to reach US$ 1529.8 million by 2029, growing at a CAGR of 3.7% from 2023 to 2029. The market is mainly driven by the significant applications of Coagulation Factor VIIa in various end use industries. The expanding demands from the Congenital Hemophilia, Acquired Hemophilia and Other, are propelling Coagulation Factor VIIa market. Prefilled Syringe, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Vial segment is estimated at % CAGR for the next seven-year period.
Due to the COVID-19 pandemic, the global Recombinant Human Coagulation VIIa market size is estimated to be worth US$ 1180 million in 2022 and is forecast to a readjusted size of US$ 1467 million by 2028 with a CAGR of 3.7% during the forecast period 2022-2028. Market driver is mainly rising number of hemophilia patients across the world. Recombinant coagulation factors, as opposed to plasma-derived counterparts, consume a very low risk for transfer of infectious diseases and their use would eliminate the risk of infection from viruses such as the human immunodeficiency virus and hepatitis C. The advancement of recombinant coagulation factors has been a major importance in hemophilia care promising nearly complete safety of individuals from the risk of transmitted infections.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Coagulation Factor VIIa, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Coagulation Factor VIIa market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Coagulation Factor VIIa market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Coagulation Factor VIIa sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Coagulation Factor VIIa covered in this report include Novo Nordisk, LFB SA HEMA Biologics, AryoGen Pharmed and GENERIUM, etc.
The global Coagulation Factor VIIa market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novo Nordisk
LFB SA HEMA Biologics
AryoGen Pharmed
GENERIUM
Global Coagulation Factor VIIa market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Coagulation Factor VIIa market, Segment by Type:
Prefilled Syringe
Vial
Global Coagulation Factor VIIa market, by Application
Congenital Hemophilia
Acquired Hemophilia
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Coagulation Factor VIIa manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Coagulation Factor VIIa in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Recombinant activated factor VII (rFVIIa) binds to exposed tissue factor at the place of tissue and vascular injury. Thrombin generated by this process activates platelets and the coagulation cascade.
The global Coagulation Factor VIIa market size is expected to reach US$ 1529.8 million by 2029, growing at a CAGR of 3.7% from 2023 to 2029. The market is mainly driven by the significant applications of Coagulation Factor VIIa in various end use industries. The expanding demands from the Congenital Hemophilia, Acquired Hemophilia and Other, are propelling Coagulation Factor VIIa market. Prefilled Syringe, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Vial segment is estimated at % CAGR for the next seven-year period.
Due to the COVID-19 pandemic, the global Recombinant Human Coagulation VIIa market size is estimated to be worth US$ 1180 million in 2022 and is forecast to a readjusted size of US$ 1467 million by 2028 with a CAGR of 3.7% during the forecast period 2022-2028. Market driver is mainly rising number of hemophilia patients across the world. Recombinant coagulation factors, as opposed to plasma-derived counterparts, consume a very low risk for transfer of infectious diseases and their use would eliminate the risk of infection from viruses such as the human immunodeficiency virus and hepatitis C. The advancement of recombinant coagulation factors has been a major importance in hemophilia care promising nearly complete safety of individuals from the risk of transmitted infections.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Coagulation Factor VIIa, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Coagulation Factor VIIa market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Coagulation Factor VIIa market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Coagulation Factor VIIa sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Coagulation Factor VIIa covered in this report include Novo Nordisk, LFB SA HEMA Biologics, AryoGen Pharmed and GENERIUM, etc.
The global Coagulation Factor VIIa market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novo Nordisk
LFB SA HEMA Biologics
AryoGen Pharmed
GENERIUM
Global Coagulation Factor VIIa market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Coagulation Factor VIIa market, Segment by Type:
Prefilled Syringe
Vial
Global Coagulation Factor VIIa market, by Application
Congenital Hemophilia
Acquired Hemophilia
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Coagulation Factor VIIa manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Coagulation Factor VIIa in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Coagulation Factor VIIa Market Overview
1.1 Coagulation Factor VIIa Product Overview
1.2 Coagulation Factor VIIa Market Segment by Type
1.2.1 Prefilled Syringe
1.2.2 Vial
1.3 Global Coagulation Factor VIIa Market Size by Type
1.3.1 Global Coagulation Factor VIIa Market Size Overview by Type (2018-2029)
1.3.2 Global Coagulation Factor VIIa Historic Market Size Review by Type (2018-2023)
1.3.3 Global Coagulation Factor VIIa Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Coagulation Factor VIIa Sales Breakdown by Type (2018-2023)
1.4.2 Europe Coagulation Factor VIIa Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Coagulation Factor VIIa Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Coagulation Factor VIIa Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Coagulation Factor VIIa Sales Breakdown by Type (2018-2023)
2 Global Coagulation Factor VIIa Market Competition by Company
2.1 Global Top Players by Coagulation Factor VIIa Sales (2018-2023)
2.2 Global Top Players by Coagulation Factor VIIa Revenue (2018-2023)
2.3 Global Top Players by Coagulation Factor VIIa Price (2018-2023)
2.4 Global Top Manufacturers Coagulation Factor VIIa Manufacturing Base Distribution, Sales Area, Product Type
2.5 Coagulation Factor VIIa Market Competitive Situation and Trends
2.5.1 Coagulation Factor VIIa Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Coagulation Factor VIIa Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Coagulation Factor VIIa as of 2022)
2.7 Date of Key Manufacturers Enter into Coagulation Factor VIIa Market
2.8 Key Manufacturers Coagulation Factor VIIa Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Coagulation Factor VIIa Status and Outlook by Region
3.1 Global Coagulation Factor VIIa Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Coagulation Factor VIIa Historic Market Size by Region
3.2.1 Global Coagulation Factor VIIa Sales in Volume by Region (2018-2023)
3.2.2 Global Coagulation Factor VIIa Sales in Value by Region (2018-2023)
3.2.3 Global Coagulation Factor VIIa Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Coagulation Factor VIIa Forecasted Market Size by Region
3.3.1 Global Coagulation Factor VIIa Sales in Volume by Region (2024-2029)
3.3.2 Global Coagulation Factor VIIa Sales in Value by Region (2024-2029)
3.3.3 Global Coagulation Factor VIIa Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Coagulation Factor VIIa by Application
4.1 Coagulation Factor VIIa Market Segment by Application
4.1.1 Congenital Hemophilia
4.1.2 Acquired Hemophilia
4.1.3 Other
4.2 Global Coagulation Factor VIIa Market Size by Application
4.2.1 Global Coagulation Factor VIIa Market Size Overview by Application (2018-2029)
4.2.2 Global Coagulation Factor VIIa Historic Market Size Review by Application (2018-2023)
4.2.3 Global Coagulation Factor VIIa Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Coagulation Factor VIIa Sales Breakdown by Application (2018-2023)
4.3.2 Europe Coagulation Factor VIIa Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Coagulation Factor VIIa Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Coagulation Factor VIIa Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Coagulation Factor VIIa Sales Breakdown by Application (2018-2023)
5 North America Coagulation Factor VIIa by Country
5.1 North America Coagulation Factor VIIa Historic Market Size by Country
5.1.1 North America Coagulation Factor VIIa Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Coagulation Factor VIIa Sales in Volume by Country (2018-2023)
5.1.3 North America Coagulation Factor VIIa Sales in Value by Country (2018-2023)
5.2 North America Coagulation Factor VIIa Forecasted Market Size by Country
5.2.1 North America Coagulation Factor VIIa Sales in Volume by Country (2024-2029)
5.2.2 North America Coagulation Factor VIIa Sales in Value by Country (2024-2029)
6 Europe Coagulation Factor VIIa by Country
6.1 Europe Coagulation Factor VIIa Historic Market Size by Country
6.1.1 Europe Coagulation Factor VIIa Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Coagulation Factor VIIa Sales in Volume by Country (2018-2023)
6.1.3 Europe Coagulation Factor VIIa Sales in Value by Country (2018-2023)
6.2 Europe Coagulation Factor VIIa Forecasted Market Size by Country
6.2.1 Europe Coagulation Factor VIIa Sales in Volume by Country (2024-2029)
6.2.2 Europe Coagulation Factor VIIa Sales in Value by Country (2024-2029)
7 Asia-Pacific Coagulation Factor VIIa by Region
7.1 Asia-Pacific Coagulation Factor VIIa Historic Market Size by Region
7.1.1 Asia-Pacific Coagulation Factor VIIa Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Coagulation Factor VIIa Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Coagulation Factor VIIa Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Coagulation Factor VIIa Forecasted Market Size by Region
7.2.1 Asia-Pacific Coagulation Factor VIIa Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Coagulation Factor VIIa Sales in Value by Region (2024-2029)
8 Latin America Coagulation Factor VIIa by Country
8.1 Latin America Coagulation Factor VIIa Historic Market Size by Country
8.1.1 Latin America Coagulation Factor VIIa Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Coagulation Factor VIIa Sales in Volume by Country (2018-2023)
8.1.3 Latin America Coagulation Factor VIIa Sales in Value by Country (2018-2023)
8.2 Latin America Coagulation Factor VIIa Forecasted Market Size by Country
8.2.1 Latin America Coagulation Factor VIIa Sales in Volume by Country (2024-2029)
8.2.2 Latin America Coagulation Factor VIIa Sales in Value by Country (2024-2029)
9 Middle East and Africa Coagulation Factor VIIa by Country
9.1 Middle East and Africa Coagulation Factor VIIa Historic Market Size by Country
9.1.1 Middle East and Africa Coagulation Factor VIIa Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Coagulation Factor VIIa Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Coagulation Factor VIIa Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Coagulation Factor VIIa Forecasted Market Size by Country
9.2.1 Middle East and Africa Coagulation Factor VIIa Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Coagulation Factor VIIa Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Novo Nordisk
10.1.1 Novo Nordisk Company Information
10.1.2 Novo Nordisk Introduction and Business Overview
10.1.3 Novo Nordisk Coagulation Factor VIIa Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Novo Nordisk Coagulation Factor VIIa Products Offered
10.1.5 Novo Nordisk Recent Development
10.2 LFB SA HEMA Biologics
10.2.1 LFB SA HEMA Biologics Company Information
10.2.2 LFB SA HEMA Biologics Introduction and Business Overview
10.2.3 LFB SA HEMA Biologics Coagulation Factor VIIa Sales, Revenue and Gross Margin (2018-2023)
10.2.4 LFB SA HEMA Biologics Coagulation Factor VIIa Products Offered
10.2.5 LFB SA HEMA Biologics Recent Development
10.3 AryoGen Pharmed
10.3.1 AryoGen Pharmed Company Information
10.3.2 AryoGen Pharmed Introduction and Business Overview
10.3.3 AryoGen Pharmed Coagulation Factor VIIa Sales, Revenue and Gross Margin (2018-2023)
10.3.4 AryoGen Pharmed Coagulation Factor VIIa Products Offered
10.3.5 AryoGen Pharmed Recent Development
10.4 GENERIUM
10.4.1 GENERIUM Company Information
10.4.2 GENERIUM Introduction and Business Overview
10.4.3 GENERIUM Coagulation Factor VIIa Sales, Revenue and Gross Margin (2018-2023)
10.4.4 GENERIUM Coagulation Factor VIIa Products Offered
10.4.5 GENERIUM Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Coagulation Factor VIIa Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Coagulation Factor VIIa Industrial Chain Analysis
11.4 Coagulation Factor VIIa Market Dynamics
11.4.1 Coagulation Factor VIIa Industry Trends
11.4.2 Coagulation Factor VIIa Market Drivers
11.4.3 Coagulation Factor VIIa Market Challenges
11.4.4 Coagulation Factor VIIa Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Coagulation Factor VIIa Distributors
12.3 Coagulation Factor VIIa Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
